Cargando…
Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material
WHO 20/136 is standard reference material for SARS−COV-2 serology assays. Standardization of serology assays that target the same antigen and class of immunoglobulin will enable comparison of results between studies that use various lab-developed and commercial assays around the world. Standardizati...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667347/ https://www.ncbi.nlm.nih.gov/pubmed/34915088 http://dx.doi.org/10.1016/j.jviromet.2021.114430 |
_version_ | 1784614372193075200 |
---|---|
author | Freeman, James Conklin, Justin |
author_facet | Freeman, James Conklin, Justin |
author_sort | Freeman, James |
collection | PubMed |
description | WHO 20/136 is standard reference material for SARS−COV-2 serology assays. Standardization of serology assays that target the same antigen and class of immunoglobulin will enable comparison of results between studies that use various lab-developed and commercial assays around the world. Standardization of assays will help better define immune correlates of protection and possibly immune correlates of vaccine efficacy. Two automated SARS−COV-2 anti-S1 RBD immunoglobulin serology assays on the Atellica IM Analyzer were calibrated to WHO 20/136 Standard Reference Material which was assigned 1000 binding antibody units (BAU/mL). The anti-S1 RBD IgG assay (sCOVG) cut-off Index of 1.00 corresponded to WHO 45.1 BAU/mL, and the anti-S1 RBD Ig Total assay (COV2T) cut-off Index of 1.00 corresponded to WHO 6.70 BAU/mL. |
format | Online Article Text |
id | pubmed-8667347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86673472021-12-14 Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material Freeman, James Conklin, Justin J Virol Methods Short Communication WHO 20/136 is standard reference material for SARS−COV-2 serology assays. Standardization of serology assays that target the same antigen and class of immunoglobulin will enable comparison of results between studies that use various lab-developed and commercial assays around the world. Standardization of assays will help better define immune correlates of protection and possibly immune correlates of vaccine efficacy. Two automated SARS−COV-2 anti-S1 RBD immunoglobulin serology assays on the Atellica IM Analyzer were calibrated to WHO 20/136 Standard Reference Material which was assigned 1000 binding antibody units (BAU/mL). The anti-S1 RBD IgG assay (sCOVG) cut-off Index of 1.00 corresponded to WHO 45.1 BAU/mL, and the anti-S1 RBD Ig Total assay (COV2T) cut-off Index of 1.00 corresponded to WHO 6.70 BAU/mL. Elsevier B.V. 2022-02 2021-12-13 /pmc/articles/PMC8667347/ /pubmed/34915088 http://dx.doi.org/10.1016/j.jviromet.2021.114430 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Freeman, James Conklin, Justin Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material |
title | Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material |
title_full | Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material |
title_fullStr | Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material |
title_full_unstemmed | Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material |
title_short | Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material |
title_sort | standardization of two sars-cov-2 serology assays to the who 20/136 human standard reference material |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667347/ https://www.ncbi.nlm.nih.gov/pubmed/34915088 http://dx.doi.org/10.1016/j.jviromet.2021.114430 |
work_keys_str_mv | AT freemanjames standardizationoftwosarscov2serologyassaystothewho20136humanstandardreferencematerial AT conklinjustin standardizationoftwosarscov2serologyassaystothewho20136humanstandardreferencematerial |